The effect of caffeine on the risk and progression of Parkinson’s disease: A meta-analysis CT Hong, L Chan, CH Bai Nutrients 12 (6), 1860, 2020 | 98 | 2020 |
Insulin resistance promotes Parkinson’s disease through aberrant expression of α-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling CT Hong, KY Chen, W Wang, JY Chiu, D Wu, TY Chao, CJ Hu, KYD Chau, ... Cells 9 (3), 740, 2020 | 94 | 2020 |
REM sleep behavior disorder (RBD) in dementia with Lewy bodies (DLB) PC Chan, HH Lee, CT Hong, CJ Hu, D Wu Behavioural neurology 2018 (1), 9421098, 2018 | 59 | 2018 |
Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models CT Hong, KY Chau, AHV Schapira Scientific reports 6 (1), 25344, 2016 | 54 | 2016 |
Newly diagnosed anemia increases risk of Parkinson’s disease: a population-based cohort study CT Hong, YH Huang, HY Liu, HY Chiou, L Chan, LN Chien Scientific reports 6 (1), 29651, 2016 | 52 | 2016 |
Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging CT Hong, LK Tsai, JS Jeng Cerebrovascular diseases 28 (4), 411-416, 2009 | 42 | 2009 |
Prevalent cerebrovascular and cardiovascular disease in people with Parkinson’s disease: a meta-analysis CT Hong, HH Hu, L Chan, CH Bai Clinical epidemiology, 1147-1154, 2018 | 41 | 2018 |
Artificial neural network based prediction of postthrombolysis intracerebral hemorrhage and death CC Chung, L Chan, OA Bamodu, CT Hong, HW Chiu Scientific reports 10 (1), 20501, 2020 | 36 | 2020 |
Plasma extracellular vesicles tau and β‐amyloid as biomarkers of cognitive dysfunction of Parkinson's disease CC Chung, L Chan, JH Chen, OA Bamodu, HW Chiu, CT Hong The FASEB Journal 35 (10), e21895, 2021 | 35 | 2021 |
Cytokine profile in plasma extracellular vesicles of Parkinson’s disease and the association with cognitive function L Chan, CC Chung, JH Chen, RC Yu, CT Hong Cells 10 (3), 604, 2021 | 34 | 2021 |
Suboptimal baseline serum vitamin B12 is associated with cognitive decline in people with Alzheimer’s disease undergoing cholinesterase inhibitor treatment HS Cho, LK Huang, YT Lee, L Chan, CT Hong Frontiers in Neurology 9, 325, 2018 | 32 | 2018 |
Incidence of poststroke seizures: A meta-analysis L Chan, CJ Hu, YC Fan, FY Li, HH Hu, CT Hong, CH Bai Journal of Clinical Neuroscience 47, 347-351, 2018 | 32 | 2018 |
Hand fine motor skill disability correlates with dementia severity WC Liou, L Chan, CT Hong, WC Chi, CF Yen, HF Liao, JH Chen, TH Liou Archives of Gerontology and Geriatrics 90, 104168, 2020 | 29 | 2020 |
Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease CT Hong, L Chan, D Wu, WT Chen, LN Chien Parkinsonism & Related Disorders 65, 224-229, 2019 | 29 | 2019 |
Association between Parkinson's disease and atrial fibrillation: a population-based study CT Hong, L Chan, D Wu, WT Chen, LN Chien Frontiers in Neurology 10, 22, 2019 | 28 | 2019 |
Effects of concomitant use of hydrogen water and photobiomodulation on Parkinson disease: a pilot study CT Hong, CJ Hu, HY Lin, D Wu Medicine 100 (4), e24191, 2021 | 27 | 2021 |
Hemichorea after hyperglycemia correction: a case report and a short review of hyperglycemia-related hemichorea at the euglycemic state HS Cho, CT Hong, L Chan Medicine 97 (10), e0076, 2018 | 27 | 2018 |
Psychotherapy for the treatment of anxiety and depression in patients with Parkinson disease: a meta-analysis of randomized controlled trials CT Hong, S Tan, TW Huang Journal of the American Medical Directors Association 22 (11), 2289-2295. e2, 2021 | 23 | 2021 |
Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson’s disease: preclinical and clinical studies CT Hong, L Chan, KY Chen, HH Lee, LK Huang, YCSH Yang, YR Liu, ... Cells 11 (21), 3468, 2022 | 22 | 2022 |
Predicting major neurologic improvement and long-term outcome after thrombolysis using artificial neural networks CC Chung, CT Hong, YH Huang, ECY Su, L Chan, CJ Hu, HW Chiu Journal of the neurological sciences 410, 116667, 2020 | 22 | 2020 |